Exhibit 10.1

Name of Participant:                    

IMS HEALTH HOLDINGS, INC.

2014 INCENTIVE AND STOCK AWARD PLAN

Stock Appreciation Rights Agreement

Pursuant to the IMS Health Holdings, Inc. 2014 Incentive and Stock Award Plan
(as amended from time to time, the “Plan”), IMS Health Holdings, Inc. (the
“Company”) has granted to the Participant named above, on the grant date listed
on Exhibit A hereto (the “Grant Date”), Stock Appreciation Rights (the “SARs”)
that may be exercised with respect to all or a portion of the number of whole
shares of Stock set forth on Exhibit A hereto, subject to the terms and
conditions set forth in this Stock Appreciation Rights Agreement (the
“Agreement”) and in the Plan. Subject to earlier termination as provided for
herein and in the Plan, the latest date on which the SARs may be exercised is
the expiration date specified on Exhibit A hereto (the “Expiration Date”). For
the avoidance of doubt, the total number of shares of Stock underlying the SARs
is subject to adjustment pursuant to Section 10 of the Plan. For purposes of
this Agreement, “Employer” shall mean the affiliate or subsidiary that employs
the Participant (to the extent the Participant is not directly employed by the
Company).

1. Nature of SARs. The SARs provide to the Participant a right to receive, upon
exercise of vested SARs in compliance with this Agreement, payment in shares of
Stock. The number of shares of Stock that shall be delivered to the Participant
upon a valid exercise of the SARs, before any reduction for withholding taxes in
accordance with Section 5, shall be determined by multiplying (i) times (ii) and
dividing the resulting product by (iii), where:

 

  (i) is the number of SARs being exercised;

 

  (ii) is the excess of (A) the Fair Market Value of one share of Stock on the
date of exercise, over (B) the “Base Price Per Share” set forth on Exhibit A;
and

 

  (iii) is the Fair Market Value of one share of Stock on the date of exercise.

Unless otherwise determined by the Company, no fractional shares of Stock will
be issued in payment upon the exercise of the SARs.

2. Vesting; Exercisability; Manner of Exercise. The SARs may not be exercised
until they have vested.

(a) Vesting Schedule. Except as set forth below or in the Plan, the SARs shall
become vested on the vesting dates set forth on Exhibit A hereto, subject to the
Participant’s continued Employment through the applicable vesting date.

(b) Exercisability. Once vested, the SARs shall be exercisable and may be
exercised at any time or times prior to the close of business on the Expiration
Date, subject to the provisions hereof and of the Plan and any procedures that
the Committee may approve from time to time. Notwithstanding any other provision
hereof or of the Plan, no SARs shall be exercisable after the Expiration Date.

(c) Method of Exercise. The Participant may exercise vested SARs by giving
notice (in such manner as is acceptable to the Company) to the Company of his or
her election to exercise such SARs. This notice shall specify the number of SARs
being exercised. For the avoidance of doubt, the Company may in its sole
discretion establish alternative means to exercise vested SARs, including
electronic forms using electronic signatures and interactive voice response
systems using PIN numbers, in a manner directed by the Company, and the SARs
shall be deemed to be exercised upon fulfillment of such alternative means.

 

1

--------------------------------------------------------------------------------

(d) Delivery of Shares Upon Exercise. Promptly following the date the SARs are
exercised, payment shall be made to the Participant in shares of Stock, in
accordance with Section 1. Payment may be made by issuance of shares in the name
of the Participant and delivery of such shares to the Participant or, in the
discretion of the Company, by issuance and delivery of such shares to a
financial institution for the account of the Participant, or in any other
commercially reasonable manner as may be determined by the Company.

(e) Restrictions on Delivered Shares. The Participant’s sales or other
dispositions of shares of Stock acquired upon exercise of the SARs will be
subject to applicable restrictions under Company policies applicable to the
Participant, including those covering insider trading by employees.

(f) Cash Settlement. Notwithstanding any provision in this Agreement to the
contrary, the Company may, in its sole discretion, settle the Participant’s SARs
in the form of (1) a cash payment to the extent settlement in shares of Stock
(i) is prohibited under local law, or (ii) would require the Participant, the
Company and/or the Employer to obtain the approval of any governmental and/or
regulatory body in the Participant’s country of residence (and/or country of
employment, if different), or (iii) is administratively burdensome; or
(2) shares of Stock, but require the Participant to immediately exercise and
sell such shares of Stock (in which case, as a condition to the grant of this
award, the Participant hereby expressly authorizes the Company to issue sales
instructions on the Participant’s behalf).

3. Use of Certain Defined Terms. Capitalized terms used in this Agreement shall
have the meaning specified in the Plan, unless a different meaning is specified
herein. In the event of a conflict between the terms and conditions of this
Agreement and the Plan, the Plan shall control, except as expressly provided in
Section 4 herein. The terms set forth below shall have the following meanings:

(a) “Disability” shall mean: (i) If the Participant is a party to an employment
or severance-benefit agreement that contains a definition of “Disability,” the
definition set forth in such agreement shall apply with respect to the
Participant under the Plan for so long as such agreement is in effect; and
(ii) otherwise, a disability that would entitle the Participant to long-term
disability benefits under the Company’s long-term disability plan in which the
Participant participates.

(b) “Employment” shall mean the Participant’s employment by, or other service
to, the Company or any of its subsidiaries.

(c) “Retirement” shall mean retirement from active Employment after attaining
age 65, or after attaining age 55 and completion of at least five (5) years of
Employment with the Company or any of its subsidiaries (including any acquired
entity with respect to which the Committee has determined to credit
pre-acquisition service for this purpose).

4. Termination of Service. If the Participant’s Employment ceases for any
reason, the SARs, to the extent not already then vested, will be immediately
forfeited and any vested SARs will be treated as follows:

(a) Generally. Subject to subsections (b), (c) and (d) below, the SARs, to the
extent vested immediately prior to the cessation of the Participant’s
Employment, will remain exercisable until the earlier of (i) 90 days following
cessation of Employment or (ii) the Expiration Date, and, unless previously
exercised, will thereupon immediately terminate.

(b) Disability, Death or Retirement. In the event of a cessation of the
Participant’s Employment by the Company by reason of the Participant’s
Disability or due to the Participant’s death or Retirement, the SARs, to the
extent vested immediately prior to such cessation of Employment, will remain
exercisable until the earlier of (i) the first anniversary of such cessation of
Employment, and (ii) the Expiration Date, and, unless previously exercised, will
thereupon immediately terminate.

(c) Termination for Cause. The SARs, whether or not vested, will terminate
immediately upon a cessation of the Participant’s Employment if such cessation
of Employment has resulted in connection with an act or failure to act
constituting Cause.

 

2

--------------------------------------------------------------------------------

(d) Other Terminations of SARs. Other provisions of the Plan and this Agreement,
including Sections 7 and 8, may result in the termination of unexercised SARs
prior to the Expiration Date.

5. Income Tax and Social Insurance Withholding. Regardless of any action the
Company and/or the Employer take with respect to any or all income tax
(including U.S. federal, state and local taxes and/or non-U.S. taxes), social
insurance, payroll tax, payment on account or other tax-related withholding
(“Tax-Related Items”), the Participant acknowledges that the ultimate liability
for all Tax-Related Items legally due by the Participant is and remains the
Participant’s responsibility and that the Company and the Employer (a) make no
representations or undertakings regarding the treatment of any Tax-Related Items
in connection with any aspect of the SARs, including the grant of the SARs, the
vesting of the SARs, the exercise of the SARs, the subsequent sale of any shares
of Stock (or cash) acquired pursuant to the SARs and the receipt of any
dividends and (b) do not commit to structure the terms of the grant or any
aspect of the SARs to reduce or eliminate the liability for Tax-Related Items.
Prior to the delivery of shares of Stock upon exercise of the SARs, if the
Participant’s country of residence (and/or the Participant’s country of
employment, if different) requires withholding of Tax-Related Items, unless
otherwise determined by the Committee, the Company shall withhold a sufficient
number of whole shares of Stock otherwise issuable upon exercise of the SARs
that have an aggregate Fair Market Value sufficient to pay the minimum
Tax-Related Items required to be withheld with respect to the shares of Stock
delivered upon such exercise of the SARs. The cash equivalent of the shares of
Stock withheld will be used to settle the obligation to withhold the Tax-Related
Items. Alternatively, the Company and/or Employer may withhold the minimum
Tax-Related Items required to be withheld with respect to the shares of Stock in
cash from the Participant’s regular salary and/or wages, or other amounts
payable to the Participant. In the event the withholding requirements are not
satisfied through the withholding of Stock or through the Participant’s regular
salary and/or wages or any other amounts payable to the Participant by the
Employer, no shares of Stock will be issued to the Participant (or the
Participant’s estate) upon exercise of the SARs unless and until satisfactory
arrangements (as determined by the Committee) have been made by the Participant
with respect to the payment of any Tax-Related Items that the Company or the
Participant’s Employer determines, in its sole discretion, must be withheld or
collected with respect to such SARs. By accepting the SARs, the Participant
expressly consents to the withholding of shares of Stock and/or withholding from
the Participant’s regular salary and/or wages or other amounts payable to the
Participant as provided for hereunder. All other Tax-Related Items related to
the SARs and any shares of Stock delivered in payment thereof are the
Participant’s sole responsibility.

6. Transferability. The SARs and this Agreement are personal to the Participant,
are non-assignable and are not transferable in any manner, by operation of law
or otherwise, other than by will or the laws of descent and distribution or as
permitted by the Committee. Any attempted transfer, assignment, pledge or other
disposition of the SARs or of any rights granted under this Agreement that is
contrary to the provisions of the Plan or this Section 6 shall be null and void.
The SARs are exercisable, during the Participant’s lifetime, only by the
Participant or his or her legal guardian, if any, and following the
Participant’s death, only by the Participant’s legal representative or legatee,
and, if the Committee permits a transfer of the SARs, by the permitted
transferee. A permitted transferee will have the rights of the Participant with
regard to any transferred SARs, subject to any limitations imposed by the
Company as a condition of permitting the transfer or otherwise.

7. Forfeiture; Recovery of Compensation.

(a) The Committee may cancel, rescind, withhold or otherwise limit or restrict
the SARs or delivery of shares upon exercise of the SARs at any time if the
Participant is not in compliance with all applicable provisions of this
Agreement and the Plan (including, but not limited to, Section 2(e), Section 6
and Section 9).

(b) By accepting the SARs, the Participant expressly acknowledges and agrees
that his or her rights, and those of any permitted transferee of the SARs, under
the SARs, including to any Stock acquired under the SARs or proceeds from the
disposition thereof, are subject to Section 9 of the Plan (including any
successor provision). Nothing in the preceding sentence shall be construed as
limiting the general application of Section 10(e) of this Agreement.

 

3

--------------------------------------------------------------------------------

8. Other Undertakings. To protect the interests of the Company and its direct
and indirect affiliates and subsidiaries (individually, an “IMS Company” and
collectively, the “IMS Companies”), including the confidential information of
the IMS Companies and the confidential information of their respective
customers, data suppliers, prospective customers and other companies with which
the IMS Companies have a business relationship, and in consideration of the
covenants and promises and other valuable consideration described in this
Agreement, the Company and the Participant agree as follows:

(a) The Participant acknowledges and agrees that he or she is bound by the
confidentiality and other covenants contained in one or more restrictive
covenant and confidentiality agreements that he or she has executed with an IMS
Company, which covenants and agreements are incorporated herein by reference and
shall survive any exercise, expiration, forfeiture or other termination of this
Agreement or the SARs issuable hereunder. The Participant also acknowledges and
agrees that the Company shall be an affiliate for purposes of such restrictive
covenant and confidentiality agreements.

(b) The Participant acknowledges that the opportunity to participate in the Plan
and the financial benefits that may accrue from such participation, is good,
valuable and sufficient consideration for the following:

 

  (i) The Participant acknowledges and agrees that he or she is and will remain
bound by the non-competition, non-solicitation and other covenants contained in
the restrictive covenant and confidentiality agreement(s) that he or she has
executed with any of the IMS Companies to the fullest extent permitted by law.

 

  (ii) The Participant further acknowledges and agrees that the period during
which the non-competition and non-solicitation covenants in such agreement(s)
will apply following a termination of Employment shall be extended from twelve
(12) months to eighteen (18) months; provided, however, that the remedies
available for breach of any non-competition or non-solicitation covenants during
such extended six-month period shall be limited to the following: (x) to the
extent then outstanding, the forfeiture of the SARs for no consideration, and
(y) to the extent the SARs have been exercised on or after the date that is 18
months before Participant’s cessation of Employment, with respect to the shares
of Stock issued upon such exercise (including shares withheld for taxes), the
Participant shall pay to the Company an amount equal to (A) the aggregate fair
market value of such shares of Stock as of the date of exercise, plus (B) the
excess, if any, of the aggregate proceeds of all sales of such shares of Stock
over the amount described under subsection (A) above. (For this purpose, the
Participant’s earliest sales of shares following such exercise will be deemed
sales of the shares acquired upon such exercise.) The Company shall also be
entitled to the foregoing remedies in the event of a material breach of any
confidentiality, non-disclosure or other similar covenant contained in the
restrictive covenant and confidentiality agreement(s) that the Participant has
executed with an IMS Company.

 

  (iii) The Participant further acknowledges and agrees to the Company’s
application, implementation and enforcement of (a) such policy set forth in
Section 8(b)(ii) of this Agreement and (b) any provision of applicable law or
Company policy relating to cancellation, recoupment, rescission or payback of
compensation and expressly agrees that the Company may take such actions as are
necessary to effectuate such policy (as applicable to the Participant) or
applicable law without further consent or action being required by the
Participant. For purposes of the foregoing, the Participant expressly and
explicitly authorizes the Company to issue instructions, on the Participant’s
behalf, to any brokerage firm and/or third party administrator engaged by the
Company to hold Participant’s shares of Stock and other amounts acquired under
the Plan to re-convey, transfer or otherwise return such shares of Stock and/or
other amounts to the Company. To the extent that the terms of this Agreement and
such policy conflict, the terms of such policy shall prevail.

 

4

--------------------------------------------------------------------------------

  (iv) By accepting the SARs, the Participant consents to one or more deductions
from any amounts any IMS Company owes the Participant from time to time in an
aggregate amount equal to all amounts described in subsection (ii) above, to the
extent such deductions are permitted by applicable law. Any such deduction from
an amount that constitutes a deferral of compensation under Code Section 409A
may only take place at the time the amount would otherwise be payable to the
Participant, except to the extent permitted by Code Section 409A.

9. Governing Law and Venue.

(a) This Agreement and all claims arising out of or based upon this Agreement or
relating to the subject matter hereof shall be governed by and construed in
accordance with the domestic substantive laws of the State of Delaware without
giving effect to any choice or conflict of laws provision or rule that would
cause the application of the domestic substantive laws of any other
jurisdiction.

(b) Any legal proceeding arising out of this Plan or this Agreement shall be
brought exclusively in the Federal or State courts located in the State of
Delaware. The Participant agrees to submit to personal jurisdiction and to venue
in those courts. The Participant further agrees to waive all legal challenges
and defenses to the appropriateness of Delaware as the site of any such legal
proceeding and to the application of the laws of the State of Delaware and any
applicable Federal laws.

10. Miscellaneous.

(a) Notice hereunder shall be given to the Company at its principal place of
business, and shall be given to the Participant at the last address shown in the
Company’s records, or in either case at such other address as one party may
subsequently furnish to the other party in writing.

(b) Notwithstanding any provisions of Agreement to the contrary, the SARs shall
be subject to any special terms and conditions for the Participant’s country of
residence (and/or country of employment, if different) set forth in the addendum
to this Agreement (the “Addendum”). Further, if the Participant transfers
residency and/or employment to another country set forth in the Addendum, at the
time of transfer, any special terms and conditions for such country will apply
to the Participant to the extent the Company determines, in its sole discretion,
that the application of such terms and conditions is necessary or advisable in
order to comply with local law, rules and regulations or to facilitate the
operation and administration of the SARs and the Plan (or the Company may
establish alternative terms and conditions as may be necessary or advisable to
accommodate the Participant’s transfer). In all circumstances, any applicable
Addendum shall constitute part of the Agreement.

(c) The Company reserves the right to impose other requirements on the SARs, any
shares of Stock acquired pursuant to the SARs and the Participant’s
participation in the Plan to the extent the Company determines, in its sole
discretion, that such other requirements are necessary or advisable in order to
comply with local law, rules and regulations or to facilitate the operation and
administration of the SARs and the Plan. Such requirements may include (but are
not limited to) requiring the Participant to sign any agreements or undertakings
that may be necessary to accomplish the foregoing.

(d) The issuance of Stock upon exercise of the SARs will be contingent upon the
Company’s receipt of any agreement, statement or other evidence that the Company
and/or the Committee may require to satisfy itself that the issuance of Stock
pursuant to the exercise of the SARs and any subsequent resale of the shares of
Stock will be in compliance with all applicable laws and regulations and with
the requirements hereof and of the Plan. The determination of the Committee as
to such compliance shall be final and binding on the Participant. The
Participant shall not be deemed to be the holder of, or to have any dividend or
other rights of a holder with respect to, any shares of Stock subject to the
SARs unless and until the SARs shall have been exercised pursuant to the terms
hereof and of the Plan, the Company shall have issued and delivered the shares
of Stock to the Participant in accordance with Sections 1 and 2 of this
Agreement, and the Participant’s name shall have been entered as the stockholder
of record on the books of the Company (if an alternative

 

5

--------------------------------------------------------------------------------

method of delivery is elected by the Company under Section 2, Participant will
be required to take appropriate steps to cause any nominee to transfer shares
into the name of the Participant in order for Participant to become a record
holder of the shares). Thereupon, the Participant shall have full voting,
dividend and other ownership rights with respect to such shares of Stock.

(e) This Agreement is subject in its entirety to the provisions of the Plan,
which are incorporated herein by reference. A copy of the Plan as in effect on
the Grant Date has been furnished to the Participant. By accepting this award of
SARs, the Participant agrees to be bound by the terms of the Plan and this
Agreement.

(f) The Agreement, the Addendum (if applicable) and the Plan constitute the
entire understanding between the Participant and the Company regarding the SARs,
and any prior agreements, commitments or negotiations concerning the SARs are
superseded.

(g) Any provision of this Agreement or the Addendum that is deemed invalid,
illegal or unenforceable in any jurisdiction shall, as to that jurisdiction and
subject to this Section, be ineffective to the extent of such invalidity,
illegality or unenforceability, without affecting in any way the remaining
provisions thereof in such jurisdiction or rendering that or any other
provisions of this Agreement and the Addendum invalid, illegal, or unenforceable
in any other jurisdiction. If any covenant should be deemed invalid, illegal or
unenforceable because its scope is considered excessive, such covenant shall be
modified so that the scope of the covenant is reduced only to the minimum extent
necessary to render the modified covenant valid, legal and enforceable. No
waiver of any provision or violation of this Agreement or the Addendum by the
Company shall be implied by the Company’s forbearance or failure to take action.

11. Data Privacy. The Company and the Employer hereby notify the Participant of
the following in relation to the Participant’s personal data and the collection,
processing and transfer of such data in relation to the award of the SARs and
the Participant’s participation in the Plan pursuant to applicable personal data
protection laws. The collection, processing and transfer of the Participant’s
personal data is necessary for the Company’s administration of the Plan and the
Participant’s participation in the Plan, and the Participant’s denial and/or
objection to the collection, processing and transfer of personal data may affect
the Participant’s ability to participate in the Plan. As such, the Participant
voluntarily acknowledges, consents and agrees (where required under applicable
law) to the collection, use, processing and transfer of personal data as
described herein. The Company and the Employer hold certain personal information
about the Participant, including (but not limited to) the Participant’s name,
home address and telephone number, date of birth, social security number or
other employee identification number, salary, nationality, job title, any shares
of Stock or directorships held in the Company, details of all SARs or any other
entitlement to shares of Stock awarded, canceled, purchased, vested, exercised,
unvested or outstanding in the Participant’s favor for the purpose of managing
and administering the Plan (“Data”). The Data may be provided by the Participant
or collected, where lawful, from third parties, and the Company and the Employer
will process the Data for the exclusive purpose of implementing, administering
and managing the Participant’s participation in the Plan. The data processing
will take place through electronic and non-electronic means according to logics
and procedures strictly correlated to the purposes for which the Data is
collected and with confidentiality and security provisions as set forth by
applicable laws and regulations in the Participant’s country of residence. Data
processing operations will be performed in a manner that minimizes the use of
personal and identification data when such operations are unnecessary for the
processing purposes sought. The Data will be accessible within the Company’s
organization only by those persons requiring access for purposes of the
implementation, administration and operation of the Plan and for the
Participant’s participation in the Plan. The Company and the Employer will
transfer Data as necessary for the purpose of implementation, administration and
management of the Participant’s participation in the Plan, and the Company
and/or the Employer may each further transfer Data to any third parties
assisting the Company in the implementation, administration and management of
the Plan. These recipients may be located in the European Economic Area, the
United States or elsewhere throughout the world. The Participant hereby
authorizes (where required under applicable law) the recipients to receive,
possess, use, retain and transfer the Data, in electronic or other form, for
purposes of implementing, administering and managing the Participant’s
participation in the Plan, including any requisite transfer of such Data as may
be required for the administration of the Plan and/or the subsequent holding of

 

6

--------------------------------------------------------------------------------

shares of Stock on the Participant’s behalf to a broker or other third party
with whom the Participant may elect to deposit any shares of Stock acquired
pursuant to the Plan. The Participant may, at any time, exercise the
Participant’s rights provided under applicable personal data protection laws,
which may include the right to (a) obtain confirmation as to the existence of
the Data, (b) verify the content, origin and accuracy of the Data, (c) request
the integration, update, amendment, deletion, or blockage (for breach of
applicable laws) of the Data, and (d) oppose, for legal reasons, the collection,
processing or transfer of the Data that is not necessary or required for the
implementation, administration and/or operation of the Plan and the
Participant’s participation in the Plan. The Participant may seek to exercise
these rights by contacting the Participant’s local human resources manager.

12. Acknowledgements and Acceptance

In accepting the SARs, the Participant acknowledges and agrees that:

(a) The Participant will have no claim or entitlement (i) to compensation or
damages in consequence of the termination of Employment for any reason
whatsoever and whether or not in breach of contract, insofar as such claim or
entitlement arises or may arise from his or her ceasing to have any rights under
the Plan or this Agreement, (ii) to exercise the SARs as a result of such
termination of Employment, except as expressly provided in this Agreement, or
(iii) from the loss or diminution in value of the SARs or shares of Stock
deliverable or delivered upon exercise of the SARs (including due to any delay
between initiation of the exercise process and delivery of shares); and, upon
the grant of the SARs and in partial consideration for his or her participation
in the Plan and this Agreement, the Participant shall be deemed irrevocably to
have waived any such claim or entitlement.

(b) If the Participant does not want to accept the SARs on the terms and
conditions set out in this Agreement, the Plan and/or any related documents, the
Participant may choose the “Decline” button. The SARs will then be cancelled and
no other benefit will be due to the Participant in lieu thereof. If Participant
does not “Decline” the SARs within thirty (30) days from the Grant Date, the
Participant shall be deemed to have accepted the SARs and shall be deemed to
have agreed to the terms and conditions set out in this Agreement, the Plan
and/or any related documents.

(c) Neither the grant of the SARs, nor the issuance of Stock upon exercise of
the SARs, will give the Participant any right to be retained in the employ or
service of the Company or any of its subsidiaries, affect the right of the
Company or any of its subsidiaries to discharge (as may otherwise be permitted
under local law) or discipline the Participant at any time or affect any right
of the Participant to terminate his or her Employment at any time.

(d) The Participant acknowledges and agrees that the Plan is discretionary in
nature and limited in duration, and may be amended, cancelled, or terminated by
the Company, in its sole discretion, at any time.

(e) The grant of SARs is a one-time benefit and does not create any contractual
or other right for the Participant to receive a grant of SARs or benefits in
lieu of SARs in the future. The terms of future Awards of SARs, if any, will be
determined by the Company in its sole discretion, including, but not limited to,
the form and timing of such Award, the number of shares of Stock subject to the
SARs, and the vesting and exercise provisions applicable to the SARs.

(f) The headings preceding the text of the sections hereof are inserted solely
for convenience of reference, and shall not constitute a part of this Agreement,
nor shall they affect its meaning, construction or effect.

(g) The grant of the SAR is not intended to be a public offering of securities
in the Participant’s country of residence (and country of employment, if
different). The Company has not submitted any registration statement, prospectus
or other filings with the local securities authorities (unless otherwise
required under local law), and the grant of the SAR is not subject to the
supervision of the local securities authorities. No employee of the Company or
any of the Company’s subsidiaries is permitted to advise the Participant on
whether the Participant should acquire Stock by exercising the SAR under the
Plan. Investment

 

7

--------------------------------------------------------------------------------

in Stock involves a degree of risk. Before deciding to acquire Stock by
exercising the SAR, the Participant should carefully consider all risk factors
relevant to the acquisition of Stock under the Plan and the Participant should
carefully review all of the materials related to the SAR and the Plan. In
addition, the Participant should consult with the Participant’s personal advisor
for professional investment advice.

(h) The Participant acknowledges and agrees that it is the Participant’s express
intent that the Agreement, the Exhibit, the Addendum and the Plan and all other
documents, notices and legal proceedings entered into, given or instituted
pursuant to the award, be drawn up in English. If the Participant has received
the Agreement, the Exhibit, the Addendum and the Plan or any other documents
related to the award translated into a language other than English, and if the
meaning of the translated version is different than the English version, the
English version shall control.

(i) As a condition to the SAR, the Participant agrees to repatriate all payments
attributable to the Stock and/or cash acquired under the Plan in accordance with
local foreign exchange rules and regulations in the Participant’s country of
residence (and country of employment, if different). In addition, the
Participant also agrees to take any and all actions, and consents to any and all
actions taken by the Company and its subsidiaries and affiliates and/or the
Employer, as may be required to allow the Company and its subsidiaries and
affiliates or the Employer to comply with local laws, rules and regulations in
the Participant’s country of residence (and country of employment, if
different). Finally, the Participant agrees to take any and all actions as may
be required to comply with the Participant’s personal obligations under local
laws, rules and regulations in the Participant’s country of residence (and
country of employment, if different).

(j) By choosing the “Accept” button, the Participant accepts the SARs as
described above and the terms and conditions set out in this Agreement, the Plan
and any related documents. Copies of the Plan and such related documents are
being provided to Participant as part of this Agreement.

 

IMS HEALTH HOLDINGS, INC. Ari Bousbib Chairman and Chief Executive Officer

 

8

--------------------------------------------------------------------------------

STOCK APPRECIATION RIGHTS AGREEMENT

PURSUANT TO IMS HEALTH HOLDINGS, INC.

2014 INCENTIVE AND STOCK AWARD PLAN

Exhibit A

 

Name of Participant:

   [insert Name of Participant]

No. of shares of Stock subject to

the Stock Apprecitation Rights:

   [insert No. of Shares]

Base Price Per Share:

   $[insert per share base price]

Grant Date:

   [insert Grant Date]

Expiration Date:

   [insert date 10 years from Grant Date]

Vesting Schedule:

 

Number of

SARs Exercisable

   Vesting Date

[                ]             (25%)

   [                    ]

[                ]             (25%)

   [                    ]

[                ]             (25%)

   [                    ]

[                ]             (25%)

   [                    ]

 

9

--------------------------------------------------------------------------------

IMS HEALTH HOLDINGS INC.

2014 Incentive and Stock Award Plan

ADDENDUM TO

STOCK APPRECIATION RIGHTS AGREEMENT

In addition to the terms of the Plan and the Agreement, the SARs are subject to
the following additional terms and conditions (the “Addendum”). All capitalized
terms as contained in this Addendum shall have the same meaning as set forth in
the Plan and this Agreement. Pursuant to Section 10(c) of the Agreement, if the
Participant transfers the Participant’s residence and/or employment to another
country reflected in an Addendum at the time of transfer, the special terms and
conditions for such country will apply to the Participant to the extent the
Company determines, in its sole discretion, that the application of such terms
and conditions is necessary or advisable in order to comply with local law,
rules and regulations or to facilitate the operation and administration of the
SAR and the Plan (or the Company may establish alternative terms and conditions
as may be necessary or advisable to accommodate the Participant’s transfer).

AUSTRALIA

1. SAR Conditioned on Satisfaction of Regulatory Obligations. If the Participant
is (a) a director of a subsidiary incorporated in Australia, or (b) a person who
is a management-level executive of a subsidiary incorporated in Australia and
who also is a director of a subsidiary incorporated outside of the Australia,
the grant of the SARs is conditioned upon satisfaction of the shareholder
approval provisions of section 200B of the Corporations Act 2001 (Cth) and the
Corporations Amendment (Improving Accountability on Termination Payments) Act in
Australia.

2. Right to Exercise SAR. Notwithstanding anything in the Agreement or the Plan
to the contrary, if the SAR vests when the fair market value per share of Stock
is equal to or less than the exercise price, the Participant may not exercise
the vested SAR until the first business day following the business day in which
the fair market value per share of Stock exceeds the exercise price of the SAR.
For the avoidance of doubt, this provision shall apply to any SAR held by a
Participant who transfers to Australia after the SAR is granted, as determined
by the Committee in its sole discretion.

CANADA

1. Exercise Procedures – No Payment with Stock. Notwithstanding any provision in
the Agreement or the Plan, if the Participant is resident in Canada, the
Participant may not pay the Exercise Price for the shares of Stock for which the
SAR is being exercised by tendering shares of Stock already owned by the
Participant.

2. Use of English Language. If the Participant is a resident of Quebec, by
accepting the SARs, the Participant acknowledges and agrees that it is the
Participant’s wish that the Agreement, this Addendum, as well as all other
documents, notices and legal proceedings entered into, given or instituted
pursuant to the award, either directly or indirectly, be drawn up in English.

Utilisation de l’anglais. Si le bénéficiaire est un résident du Québec, en
acceptant l’Attribution, le bénéficiaire reconnaît et accepte avoir requis que
le Contrat, la présente Annexe, ainsi que tous autres documents, avis et
procédures judiciaires, exécutés, donnés ou intentés en vertu de, ou liés
directement ou indirectement à, la présente Attribution soient rédigés en
anglais.

 

10

--------------------------------------------------------------------------------

FRANCE

1. English Language. By accepting the SARs, the Participant acknowledges and
agrees that it is the Participant’s wish that the Agreement, this Addendum, as
well as all other documents, notices and legal proceedings entered into, given
or instituted pursuant to the award, either directly or indirectly, be drawn up
in English.

Langue anglaise. Le bénéficiaire admet et convient que c’est l’intention exprès
du bénéficiaire que l’Accord, le Plan et tous les autres documents, remarque et
les poursuites judiciaires entrées, données ou instituées conformément à l’SAR,
être établi dans l’anglais. Si le bénéficiaire a reçu l’Accord, le Plan ou
autres documents rattachés à l’SAR traduite dans une langue autre que l’anglais
et si le sens de la version traduite est différent que la version anglaise, la
version anglaise contrôlera.

HONG KONG

1. Important Notice. WARNING: The contents of the Agreement, the Addendum, the
Plan, and all other materials pertaining to the SARs and/or the Plan have not
been reviewed by any regulatory authority in Hong Kong. The Participant is
hereby advised to exercise caution in relation to the offer thereunder. If the
Participant has any doubts about any of the contents of the aforesaid materials,
the Participant is encouraged to obtain independent professional advice.

2. Nature of the Plan. The Company specifically intends that the Plan will not
be treated as an occupational retirement scheme for purposes of the Occupational
Retirement Schemes Ordinance (“ORSO”). To the extent any court, tribunal or
legal/regulatory body in Hong Kong determines that the Plan constitutes an
occupational retirement scheme for the purposes of ORSO, the grant of the SARs
shall be null and void.

MEXICO

1. Commercial Relationship. The Participant expressly recognizes that the
Participant’s participation in the Plan and the Company’s grant of SARs does not
constitute an employment relationship between the Participant and the Company.
The Participant has been granted the SARs as a consequence of the commercial
relationship between the Company and the Employer, and the Employer is the
Participant’s sole employer. Based on the foregoing, (a) the Participant
expressly recognizes that the Plan and the benefits the Participant may derive
from the Participant’s participation in the Plan does not establish any rights
between the Participant and the Employer that employs the Participant, (b) the
Plan and the benefits the Participant may derive from the Participant’s
participation in the Plan are not part of the employment conditions and/or
benefits provided by the Employer that employs the Participant, and (c) any
modifications or amendments of the Plan by the Company, or a termination of the
Plan by the Company, shall not constitute a change or impairment of the terms
and conditions of the Participant’s employment with the Employer that employs
the Participant.

2. Extraordinary Item of Compensation. The Participant expressly recognizes and
acknowledges that the Participant’s participation in the Plan is a result of the
discretionary and unilateral decision of the Company, as well as the
Participant’s free and voluntary decision to participate in the Plan in accord
with the terms and conditions of the Plan, the Agreement, and this Addendum. As
such, the Participant acknowledges and agrees that the Company may, in its sole
discretion, amend and/or discontinue the Participant’s participation in the Plan
at any time and without any liability. The value of the SARs is an extraordinary
item of compensation outside the scope of the Participant’s employment contract,
if any. The SARs are not part of the Participant’s regular or expected
compensation for purposes of calculating any severance, resignation, redundancy,
end of service payments, bonuses, long-service awards, pension or retirement
benefits, or any similar payments, which are the exclusive obligations of the
Employer.

 

11

--------------------------------------------------------------------------------

BY SIGNING BELOW, THE PARTICIPANT ACKNOWLEDGES, UNDERSTANDS AND AGREES TO THE
PROVISIONS OF THE PLAN, THE AGREEMENT AND THIS ADDENDUM.

PLEASE SIGN AND RETURN THIS ADDENDUM VIA EMAIL NO LATER THAN [INSERT DATE] TO
[INSERT].

 

 

       

 

Participant Signature       Participant Name (Printed)

 

      Date      

NETHERLANDS

1. Waiver of Termination Rights. The Participant waives any and all rights to
compensation or damages as a result of any termination of employment for any
reason whatsoever, insofar as those rights result or may result from (a) the
loss or diminution in value of such rights or entitlements under the Plan, or
(b) the Participant ceasing to have rights under, or ceasing to be entitled to
SARs or other awards under the Plan as a result of such termination.

SINGAPORE

1. Qualifying Person Exemption. The grant of the SARs under the Plan is being
made pursuant to the “Qualifying Person” exemption” under section 273(1)(f) of
the Securities and Futures Act (Chapter 289) (“SFA”). The Plan has not been
lodged or registered as a prospectus with the Monetary Authority of Singapore.
The Participant should note that, as a result, the SARs are subject to section
257 of the SFA and the Participant will not be able to make (a) any subsequent
sale of Stock in Singapore or (ii) any offer of such subsequent sale of shares
of Stock subject to the SARs in Singapore, unless such sale or offer is made
pursuant to the exemptions under Part XIII Division (1) Subdivision (4) (other
than section 280) of the SFA (Chapter 289, 2011 Ed.).

SPAIN

1. Acknowledgement of Discretionary Nature of the Plan; No Vested Rights. In
accepting the SARs, the Participant acknowledges that the Participant consents
to participation in the Plan and has received a copy of the Plan. The
Participant understand that the Company has unilaterally, gratuitously and in
its sole discretion granted SARs under the Plan to individuals who may be
employees of the Company or its subsidiaries throughout the world. The decision
is a limited decision that is entered into upon the express assumption and
condition that any grant will not economically or otherwise bind the Company or
any of its subsidiaries on an ongoing basis. Consequently, the Participant
understands that the SARs are granted on the assumption and condition that the
SARs and Stock acquired upon exercise of the SARs shall not become a part of any
employment contract (either with the Company or any of its subsidiaries) and
shall not be considered a mandatory benefit, salary for any purposes (including
severance compensation) or any other right whatsoever. In addition, the
Participant understands that this grant would not be made to the Participant but
for the assumptions and conditions referenced above. Thus, the Participant
acknowledges and freely accepts that should any or all of the assumptions be
mistaken or should any of the conditions not be met for any reason; the SARs
shall be null and void.

The Participant understands and agrees that, as a condition of the grant of the
SARs, any unvested SARs as of the date the Participant ceases active employment
and any vested portion of the SARs not exercised within the post-termination
exercise period set out in the Agreement will be forfeited without entitlement
to the underlying shares of Stock or to any amount of indemnification in the
event of the termination of employment by reason of, but not limited to,
(i) material modification of the terms of employment under Article 41 of the
Workers’ Statute or (ii) relocation under Article 40 of the Workers’ Statute.
The Participant acknowledges that the Participant has read and specifically
accepts the conditions referred to in the Agreement regarding the impact of a
termination of employment on the Participant’s SARs.

 

12

--------------------------------------------------------------------------------

BY SIGNING BELOW, THE PARTICIPANT ACKNOWLEDGES, UNDERSTANDS AND AGREES TO THE
PROVISIONS OF THE PLAN, THE AGREEMENT AND THIS ADDENDUM.

PLEASE SIGN AND RETURN THIS ADDENDUM VIA EMAIL NO LATER THAN [INSERT DATE] TO
[INSERT].

 

 

       

 

Participant Signature       Participant Name (Printed)

 

Date

     

UNITED KINGDOM

1. Exercise Procedures – No Payment with Stock. Notwithstanding anything in
Section 5 of the Agreement to the contrary, if the Participant is resident in
the United Kingdom, the Participant shall not be permitted to use existing
shares of Stock for exercising the SARs and paying the Exercise Price.

2. Income Tax and Social Insurance Contribution Withholding. The following
provision supplements Section 5 of the Agreement:

If payment or withholding of the income tax due in connection with the SARs is
not made within ninety (90) days after the end of the UK tax year in which the
event giving rise to the income tax liability occurs or such other period
specified in section 222(1)(c) of the U.K. Income Tax (Earnings and Pensions)
Act 2003 (the “Due Date”), the amount of any uncollected income tax shall
constitute a loan owed by the Participant to the Employer, effective as of the
Due Date. The Participant acknowledges and agrees that the loan will bear
interest at the then-current official rate of Her Majesty’s Revenue & Customs
(“HMRC”), it shall be immediately due and repayable, and the Company or the
Employer may recover it at any time thereafter by any of the means referred to
in the Agreement. Notwithstanding the foregoing, if the Participant is a
director or executive officer of the Company (within the meaning of
Section 13(k) of the U.S. Securities and Exchange Act of 1934, as amended), the
Participant will not be eligible for a loan from the Company or Employer to
cover the income tax liability. In the event that the Participant is a director
or executive officer and income tax is not collected from or paid by the
Participant by the Due Date, the amount of any uncollected income tax will
constitute a benefit to the Participant on which additional income tax and
national insurance contributions (“NICs”) will be payable. The Participant will
be responsible for reporting any income tax and for reimbursing the Company or
Employer the value of any employee NICs due on this additional benefit.

3. Exclusion of Claim. The Participant acknowledges and agrees that the
Participant shall have no entitlement to compensation or damages insofar as such
entitlement arises or may arise from the Participant’s ceasing to have rights
under or to be entitled to exercise the Participant’s SAR as a result of such
termination (whether the termination is in breach of contract or otherwise), or
from the loss or diminution in value of the Participant’s SAR. Upon the grant of
the Participant’s SAR, the Participant shall be deemed to have waived
irrevocably any such entitlement.

*    *    *    *    *

 

13